Siemens Lab-Based SARS-CoV-2 Antigen Assay (CoV2Ag) Obtains CE Mark for Use with Its High-Throughput Analyzers
Siemens Healthineers’ (Erlangen, Germany) laboratory-based SARS-CoV-2 Antigen Assay (CoV2Ag) has obtained CE Mark and is now offered for the Atellica Solution and ADVIA Centaur analyzers, widely available in laboratories worldwide. More...25 Feb 2021
PerkinElmer Launches New Highly Sensitive Point of Care COVID-19 Antigen Test for Mass Screening
PerkinElmer, Inc. (Waltham, MA; USA) has launched the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. More...24 Feb 2021
World’s First AI Rapid Antigen Test System for COVID-19 Delivers Highly Accurate Results on Smartphone Within 5-8 Minutes
The world’s first rapid COVID-19 antigen test system using artificial intelligence (AI) could revolutionize medical diagnostics, enabling early disease detection with consistent and accurate results. More...23 Feb 2021
Agilent Launches New Immunoassay Kit to Detect SARS-CoV-2 Antibodies
Agilent Technologies (Santa Clara, CA, USA) has launched the Agilent Dako SARS-CoV-2 IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit intended for the qualitative detection of immunoglobulin G (IgG) antibodies to SARS-CoV-2 in human serum or plasma. More...22 Feb 2021
First-Ever Highly Sensitive Antibody Tests Could Detect Infection with All Known Human Coronaviruses, Including New SARS-CoV-2 Variants
Scientists have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2. More...19 Feb 2021
Gold Member
Turnkey Packaging Solution
HLX
New
PSA Test
Human Semen Rapid Test
New
Centrifuge
Centrifuge 5430/ 5430 R
In Other News
New Diagnostic Device Identifies COVID-19 Patients at Risk of Potentially Lethal Cytokine Storm
Saliva Tests Are as Accurate and Effective as Nasopharyngeal Tests in Precisely Diagnosing COVID-19, Finds Study
Thermo Fisher’s TaqPath COVID-19, Flu A, Flu B Combo Kit Granted FDA Emergency Use Authorization
Eurofins Launches New Ultra-Fast Extraction-Free RT-PCR Method and Upgrades its SARS-CoV-2 RT-PCR Assay
Blood Biomarker Test Rapidly Identifies COVID-19 Patients Likely to Develop Severe Infection and Require Ventilator
Bio-Rad’s Multi-Target Reliance SARS-CoV-2/FluA/FluB RT-PCR and Reliance SARS-CoV-2 RT-PCR Assay Kits Granted FDA EUA
Eurofins Launches Quantitative Antibody Test to Measure Immune Response to COVID-19 and Vaccines
Portable, Handheld COVID-19 Test Produces Laboratory-Quality Results within 15 Minutes in Any Setting
Portable Suitcase Mini-Laboratory for Rapid Detection of SARS-CoV-2 Provides Test Results as Good as PCR Test in Real Time
Novel Antibody Tests Reveal Complexity of Immune Response to COVID-19
New ELISA-Type Immunologic Test Studies Seroprevalence Against SARS-CoV-2
DVD Technology-Based System Quickly and Inexpensively Detects SARS-CoV-2 Antigens and Specific Antibodies
New Rapid COVID-19 Test Beats ELISA Method in Identifying SARS-CoV-2 Antibodies in Blood Within Just 12 Minutes
Liquid Biopsy Allows Monitoring of COVID-19 Damage to Cells, Tissues, and Organs
COVID-19 Diagnostic Skin Test to Measure SARS-CoV-2 Exposure and T Cell Immunity
Non-Invasive Blood Test Uses Cell-Free DNA to Tracks Organ Injury from COVID-19
POC Plasmonic COVID-19 Test Uses Sensor Technology to Detect Coronavirus in Less than 45 Minutes
AI Model for Early Detection of SARS-CoV-2 in Children Could Pave Way for Rapid Bedside COVID-19 Diagnostic Device
Becton Dickinson Launches Assay for Determining COVID-19 Patients’ Risk of IMV and Mortality at Hospitalization
Pioneering Automated COVID-19 Test Robot Can Process 20,000 Samples for SARS-CoV-2 Testing Per 24 Hours
10-Minute COVID-19 Diagnostic Test Based on Nanoparticles Identifies IgG Antibodies and Costs Only Fifth of Market Average
New Simple, 15-Minute Sample-to-Answer COVID-19 Test Used with Desktop Detection System Costs Less than USD 2
Hand-Held Biosensor Device Could Enable Immediate, Sensitive Point-of-Care Detection of SARS-CoV-2 from Saliva
